|
|
Blood, 1 June 2006, Vol. 107, No. 11, pp. 4338-4345.
Prepublished online as a Blood First Edition Paper on February 7, 2006; DOI 10.1182/blood-2005-12-5021.
Previous Article | Next Article 
Submitted December 20, 2005
Accepted January 28, 2006
SHIP-deficiency enhances HSC proliferation and survival but compromises homing and repopulation
Caroline Desponts, Amy L Hazen, Kim H Paraiso, and William G Kerr*
Immunology Program, H. Lee Moffitt Comprehensive Cancer Center and Research Institute and the Departments of Interdisciplinary Oncology, University of South Florida, Tampa, FL, USA; Biochemistry and Molecular Biology, College of Medicine, University of South Florida, Tampa, FL, USA
Immunology Program, H. Lee Moffitt Comprehensive Cancer Center and Research Institute and the Departments of Interdisciplinary Oncology, University of South Florida, Tampa, FL, USA
* Corresponding author; email: kerrw{at}moffitt.usf.edu.
The SH2-domain-containing Inositol 5'-Phosphatase-1 (SHIP) has the potential to modulate multiple signaling pathways downstream of receptors that impact hematopoietic stem cell (HSC) biology. Therefore, we postulated that SHIP might play an important role in HSC homeostasis and function. Consistent with this hypothesis, HSC proliferation and numbers are increased in SHIP-/- mice. Despite expansion of the compartment, SHIP-/- HSC exhibit reduced capacity for long-term repopulation. Interestingly, we observe that SHIP-/- stem/progenitor cells home inefficiently to BM and consistent with this finding they have reduced surface levels of both CXCR4 and VCAM-1. These studies demonstrate that SHIP is critical for normal HSC function, homeostasis and homing.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Wang, G. Li, W. Tse, and K. D. Bunting
Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement
Blood,
May 14, 2009;
113(20):
4856 - 4865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kang, S. Elf, S. Dong, T. Hitosugi, K. Lythgoe, A. Guo, H. Ruan, S. Lonial, H. J. Khoury, I. R. Williams, et al.
Fibroblast Growth Factor Receptor 3 Associates with and Tyrosine Phosphorylates p90 RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation
Mol. Cell. Biol.,
April 15, 2009;
29(8):
2105 - 2117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Hazen, M. J. Smith, C. Desponts, O. Winter, K. Moser, and W. G. Kerr
SHIP is required for a functional hematopoietic stem cell niche
Blood,
March 26, 2009;
113(13):
2924 - 2933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Collazo, D. Wood, K. H. T. Paraiso, E. Lund, R. W. Engelman, C.-T. Le, D. Stauch, K. Kotsch, and W. G. Kerr
SHIP limits immunoregulatory capacity in the T-cell compartment
Blood,
March 26, 2009;
113(13):
2934 - 2944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. T. Paraiso, T. Ghansah, A. Costello, R. W. Engelman, and W. G. Kerr
Induced SHIP Deficiency Expands Myeloid Regulatory Cells and Abrogates Graft-versus-Host Disease
J. Immunol.,
March 1, 2007;
178(5):
2893 - 2900.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|